Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mydicar (1 trial)
ranolazine (ranexa) (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
vitis vinifera (1 trial)
Atrial Fibrillation (Phase 2)
Cardiomyopathies (Phase 2)
Cardiomyopathy, Dilated (Phase 2)
Heart Failure (Phase 2)
Trials (4 total)
Trial APIs (4 total)